skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8830

A review of daptomycin for injection (Cubicin) in the treatment of complicated skin and skin structure infections

(2316) Views  (591) Full article downloads

Authors: D Matthew Shoemaker, Jikerkhoun Simou, William E Roland

Published Date January 2006 Volume 2006:2(2) Pages 169 - 174
DOI: http://dx.doi.org/10.2147/TCRM.S

D Matthew Shoemaker, Jikerkhoun Simou, William E Roland

 

Division of Infectious Diseases, University of Missouri Hospital, Columbia, MO, USA

 

Abstract: Daptomycin is a novel bactericidal antibiotic with excellent activity against grampositive organisms. It is a large cyclic lipopeptide with a unique mechanism of action. Daptomycin is given once a day and is renally cleared, requiring dose adjustment in patients with impaired renal function. Unfortunately, there have been case reports of resistant grampositive organisms. Daptomycin is generally well tolerated, though myopathy has been reported. 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors should be stopped in patients on daptomycin. Daptomycin shows promise in experimental models of endocarditis, meningitis, ventriculitis, and peritonitis, and is currently approved for use in skin and soft-tissue infections. Daptomycin is a welcome newcomer to the gram-positive antimicrobial arsenal.

 

Keywords: daptomycin, lipopeptide, antibiotic, skin infection








Readers of this article also read:

Fosphenytoin for the treatment of status epilepticus: an evidence-based assessment of its clinical and economic outcomes
Exacerbation rate, health status and mortality in COPD – a review of potential interventions
The pathophysiology of bronchiectasis
ABO and rhesus blood group distribution in Kurds
Anesthesiologists’ perception of patients’ anxiety under regional anesthesia
Retinal nerve fiber layer thickness in recovered and persistent amblyopia
Nanostructured delivery system for zinc phthalocyanine: preparation, characterization, and phototoxicity study against human lung adenocarcinoma A549 cells
Subchronic toxicity (90 days) of StemEnhance™ in Wistar rats
Solid self-nanoemulsifying cyclosporin A pellets prepared by fluid-bed coating: preparation, characterization and in vitro redispersibility
Evaluation of analgesic efficacy of bromfenac sodium ophthalmic solution 0.09% versus ketorolac tromethamine ophthalmic solution 0.5% following LASEK or Epi-LASIK